biomarker panel
Valted Seq Lands Exclusive Rights to Evaluate Johns Hopkins Neurodegenerative Disease Dx Assays
The biomarker assays could one day be used as companion diagnostics for new treatments of Parkinson's and related diseases.
Neurodegenerative Disease Testing Firm CND Life Sciences Closes $2.4M Seed Financing Round
The financing will go toward the expansion of the company's laboratory operations and acceleration of the sales and marketing efforts of its Syn-One Test.
Illumina, Geneseeq Technology to Collaborate on IVD Cancer Testing Kits in China
The deal to create a comprehensive genomic profiling test for Illumina's NextSeq 550Dx comes months after the instrument received regulatory approval in China.
Illumina, PierianDx Expand Partnership on Cancer Panel Test Reporting
The deal builds on a non-exclusive partnership signed in January 2019 and PierianDx will now support three more Illumina cancer sequencing assays.
SpeeDx Expanding MDx Portfolio With Respiratory Virus Host-Response Test
The Sydney, Australia-based firm has licensed a single biomarker which it plans to develop into a test for triaging COVID-19 patients.
Feb 12, 2020
Dec 10, 2019
Nov 19, 2019
Oct 30, 2019
Sep 10, 2019
Jun 26, 2019
Vermillion Eyes $17M in Public Offering of Stock
Jun 25, 2019